{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:48:01Z","timestamp":1787060881580,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1076802C, TCVGH-1076803C"],"award-info":[{"award-number":["TCVGH-1076802C, TCVGH-1076803C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The relationship between cancer and vitiligo has been explored but with inconsistent results. To examine the long-term cancer risk in vitiligo patients, we conducted a retrospective nationwide cohort study. From the National Health Insurance Research Database of Taiwan, a total of 13,824 vitiligo patients were identified and matched with 55,296 reference subjects without vitiligo by age, gender, and propensity score estimated by major comorbidities from 1997 to 2013. Demographic characteristics and comorbidities were compared between these two groups. Incidence rate ratios and hazard ratios (HRs) were calculated to examine cancer risks. The 16-year incidence rates of overall cancers were 621.06 (566.56\u2013675.55) and 726.99 (697.24\u2013756.74) per 100,000 person-years in the vitiligo and reference groups. Patients with vitiligo showed a significantly decreased risk of overall cancers [adjusted HR, 0.85; 95% confidence interval (CI), 0.77 to 0.93,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001] compared with reference subjects without vitiligo after adjusting for age, sex, comorbidities, and treatments. The risks of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) were significantly reduced (adjusted HR 0.21, 95% CI 0.11\u20130.38,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), as well as internal malignancies (adjusted HR 0.89, 95% CI 0.81\u20130.99,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.026). The results were consistent across different subgroups of patients, including male gender, ages more than 40\u00a0years, and those receiving long-term systemic disease-modifying antirheumatic drugs and phototherapies. Information related to phenotype, disease duration, vitiligo lesion sites, family history of vitiligo or cancer, occupation, and personal lifestyle was not included in the database. Vitiligo is associated with reduced risks of BCC and SCC, as well as internal malignancies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-99786-9","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T09:24:52Z","timestamp":1634030692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan"],"prefix":"10.1038","volume":"11","author":[{"given":"Yu-Ching","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu J.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"99786_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13671-014-0098-6","volume":"4","author":"NB Silverberg","year":"2015","unstructured":"Silverberg, N. B. The epidemiology of vitiligo. Curr. Dermatol. Rep. 4, 36\u201343 (2015).","journal-title":"Curr. Dermatol. Rep."},{"issue":"1","key":"99786_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., Harris, J. E; Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J. Am. Acad. Dermatol. 77(1), 1\u201313 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"99786_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mehy.2009.08.008","volume":"74","author":"D Michelsen","year":"2010","unstructured":"Michelsen, D. The Double Strike Hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma. Med. Hypotheses 74(1), 67\u201370 (2010).","journal-title":"Med. Hypotheses"},{"issue":"7","key":"99786_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/exd.13069","volume":"26","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert, R. & van Geel, N. Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo. Exp. Dermatol. 26(7), 630\u2013634 (2017).","journal-title":"Exp. Dermatol."},{"issue":"22","key":"99786_CR5","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.3390\/ijms20225731","volume":"20","author":"CM Failla","year":"2019","unstructured":"Failla, C. M., Carbone, M. L., Fortes, C., Pagnanelli, G. & Dtri, S. Melanoma and vitiligo: In good company. Int. J. Mol. Sci. 20(22), 5731 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"99786_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/000155598442944","volume":"78","author":"B Lindel\u00f6f","year":"1998","unstructured":"Lindel\u00f6f, B., Hedblad, M. A. & Sigurgeirsson, B. On the association between vitiligo and malignant melanoma. Acta Derm. Venereol. 78(6), 483\u2013484 (1998).","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"99786_CR7","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jaad.2009.06.072","volume":"61","author":"JJ Nordlund","year":"2009","unstructured":"Nordlund, J. J. Nonmelanoma skin cancer in vitiligo patients. J. Am. Acad. Dermatol. 61(6), 1080\u20131081 (2009).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"99786_CR8","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.jid.2018.03.1511","volume":"138","author":"W Wu","year":"2018","unstructured":"Wu, W. et al.; 23andMe Research Team. Inverse relationship between vitiligo-related genes and skin cancer risk. J. Invest. Dermatol. 138(9), 2072\u20132075 (2018).","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"99786_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bjd.12111","volume":"168","author":"HE Teulings","year":"2013","unstructured":"Teulings, H. E. et al. Decreased risk of melanoma and non-melanoma skin cancer in patients with vitiligo: A survey among 1307 patients and their partners. Br. J. Dermatol. 168(1), 162\u2013171 (2013).","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"99786_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.det.2016.11.003","volume":"35","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues, M. Skin cancer risk (nonmelanoma skin cancers\/melanoma) in vitiligo patients. Dermatol. Clin. 35(2), 129\u2013134 (2017).","journal-title":"Dermatol. Clin."},{"issue":"6","key":"99786_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi, A. et al. Markedly reduced incidence of melanoma and non-melanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J. Am. Acad. Dermatol. 71(6), 1110\u20131116 (2014).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"99786_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/bjd.16703","volume":"179","author":"L Ban","year":"2018","unstructured":"Ban, L., Labbouz, S., Grindlay, D., Batchelor, J. M. & Ratib, S. Risk of skin cancer in people with vitiligo: A systematic review and meta-analysis. Br. J. Dermatol. 179(4), 971\u2013972 (2018).","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"99786_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2340\/00015555-2179","volume":"96","author":"SM Hammoud","year":"2016","unstructured":"Hammoud, S. M., Kruis, R. W. & Sigurdsson, V. Prediction of the occurrence of melanoma and non-melanoma skin cancer in patients with vitiligo. Acta Derm. Venereol. 96(1), 106\u2013107 (2016).","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"99786_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000057881","volume":"204","author":"KU Schallreuter","year":"2002","unstructured":"Schallreuter, K. U., Tobin, D. J. & Panske, A. Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 204(3), 194\u2013201 (2002).","journal-title":"Dermatology"},{"issue":"6","key":"99786_CR15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jaad.2008.09.033","volume":"60","author":"CL Hexsel","year":"2009","unstructured":"Hexsel, C. L. et al. Incidence of non-melanoma skin cancer in a cohort of patients with vitiligo. J. Am. Acad. Dermatol. 60(6), 929\u2013933 (2009).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"99786_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.18632\/oncotarget.323","volume":"2","author":"KT Byrne","year":"2011","unstructured":"Byrne, K. T. & Turk, M. J. New perspectives on the role of vitiligo in immune responses to melanoma. Oncotarget 2(9), 684\u2013694 (2011).","journal-title":"Oncotarget"},{"issue":"4","key":"99786_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/bjd.18247","volume":"182","author":"HS Kim","year":"2020","unstructured":"Kim, H. S. et al. The incidence and survival of melanoma and non-melanoma skin cancer in patients with vitiligo: A nationwide population-based matched cohort study in Korea. Br. J. Dermatol. 182(4), 907\u2013915 (2020).","journal-title":"Br. J. Dermatol."},{"key":"99786_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2020.03.004","author":"MG Jorgensen","year":"2020","unstructured":"Jorgensen, M. G., Toyserkani, N. M., Egeberg, A. & Sorensen, J. A. Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study. JAAD Int. https:\/\/doi.org\/10.1016\/j.jdin.2020.03.004 (2020).","journal-title":"JAAD Int."},{"issue":"11","key":"99786_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1200\/JCO.18.01223","volume":"37","author":"JM Bae","year":"2019","unstructured":"Bae, J. M. et al. Markedly reduced risk of internal malignancies in patients with vitiligo: A nationwide population-based cohort study. J. Clin. Oncol. 37(11), 903\u2013911 (2019).","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"99786_CR20","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/ijerph15091847","volume":"15","author":"CY Li","year":"2018","unstructured":"Li, C. Y. et al. Cancer risks in vitiligo patients: A nationwide population-based study in Taiwan. Int. J. Environ. Res. Public Health. 15(9), 1847 (2018).","journal-title":"Int. J. Environ. Res. Public Health."},{"issue":"3","key":"99786_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.det.2014.03.004","volume":"32","author":"EideMJ KozmaB","year":"2014","unstructured":"KozmaB, EideMJ. Photocarcinogenesis: An epidemiologic perspective on ultraviolet light and skin cancer. Dermatol. Clin. 32(3), 301\u2013313 (2014).","journal-title":"Dermatol. Clin."},{"issue":"2","key":"99786_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.det.2016.11.007","volume":"3","author":"T Passeron","year":"2017","unstructured":"Passeron, T. Medical and maintenance treatments for vitiligo. Dermatol. Clin. 3(2), 163\u2013170 (2017).","journal-title":"Dermatol. Clin."},{"key":"99786_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum, P. R. & Rubin, D. B. Reducing bias in observational studies using subclassification on the propensity score. J. Am. Stat. Assoc. 79, 516\u2013524 (1984).","journal-title":"J. Am. Stat. Assoc."},{"issue":"3","key":"99786_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","volume":"114","author":"CY Hsieh","year":"2015","unstructured":"Hsieh, C. Y., Chen, C. H., Li, C. Y. & Lai, M. L. Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. J. Formos. Med. Assoc. 114(3), 254\u2013259 (2015).","journal-title":"J. Formos. Med. Assoc."},{"issue":"5","key":"99786_CR25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1053\/j.gastro.2009.07.060","volume":"137","author":"CY Wu","year":"2009","unstructured":"Wu, C. Y. et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 137(5), 1641\u20131648 (2009).","journal-title":"Gastroenterology"},{"key":"99786_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jaad.2015.04.028","volume":"73","author":"TC Hua","year":"2015","unstructured":"Hua, T. C. et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J. Am. Acad. Dermatol. 73, 249\u2013254 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"99786_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2012.12.966","volume":"69","author":"YJ Chen","year":"2013","unstructured":"Chen, Y. J., Wu, C. Y., Shen, J. L., Chen, T. T. & Chang, Y. T. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: Results of a nationwide cohort study from Taiwan. J. Am. Acad. Dermatol. 69(1), 25\u201333 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"99786_CR28","first-page":"151","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. Optimal caliber width for propensity score matching when estimating differences in means and differences in proportions in observational studies. Phamarceut. Stat. 10, 151\u2013161 (2011).","journal-title":"Phamarceut. Stat."},{"issue":"10","key":"99786_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/pds.4267","volume":"27","author":"WH Kao","year":"2018","unstructured":"Kao, W. H. et al. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan. Pharmacoepidemiol. Drug Saf. 27(10), 1060\u20131066 (2018).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5715","key":"99786_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/bmj.3.5715.148","volume":"3","author":"PD Wright","year":"1970","unstructured":"Wright, P. D., Venables, C. W. & Dawber, R. P. Vitiligo and gastric carcinoma. Br. Med. J. 3(5715), 148 (1970).","journal-title":"Br. Med. J."},{"issue":"2","key":"99786_CR31","first-page":"199","volume":"74","author":"GA Alexander","year":"1982","unstructured":"Alexander, G. A. Vitiligo associated with kaposi\u2019s sarcoma. J. Natl. Med. Assoc. 74(2), 199\u2013203 (1982).","journal-title":"J. Natl. Med. Assoc."},{"issue":"3","key":"99786_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/0001555552229232","volume":"52","author":"A Lassus","year":"1972","unstructured":"Lassus, A., Apajalahti, A., Blomqvist, K., Mustakallio, M. & Kiistala, U. Vitiligo and Neoplasms. Acta Derm. Venereol 52(3), 229\u2013232 (1972).","journal-title":"Acta Derm. Venereol"},{"key":"99786_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","volume":"74","author":"L Gill","year":"2016","unstructured":"Gill, L. et al. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. J. Am. Acad. Dermatol. 74, 295\u2013302 (2016).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"99786_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2229-5178.101812","volume":"3","author":"OA Bakry","year":"2012","unstructured":"Bakry, O. A., Hammam, M. A. & Wahed, M. M. A. Immunohistochemical detection of P53 and Mdm2 in vitiligo. Indian Dermatol. Online J. 3(3), 171\u2013176 (2012).","journal-title":"Indian Dermatol. Online J."},{"key":"99786_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00403-011-1165-5","volume":"303","author":"A Feily","year":"2011","unstructured":"Feily, A. & Pazyar, N. Why vitiligo is associated with fewer risk of skin cancer? Providing a molecular mechanism. Arch Dermatol. Res. 303, 623\u2013624 (2011).","journal-title":"Arch Dermatol. Res."},{"issue":"3","key":"99786_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/phpp.12443","volume":"35","author":"TL Lin","year":"2019","unstructured":"Lin, T. L. et al. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study. Photodermatol. Photoimmunol. Photomed. 35(3), 164\u2013171 (2019).","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"5","key":"99786_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamadermatol.2020.0218","volume":"156","author":"JM Bae","year":"2020","unstructured":"Bae, J. M. et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long-term narrowband UV-B phototherapy. JAMA Dermatol. 156(5), 529\u2013537 (2020).","journal-title":"JAMA Dermatol."},{"key":"99786_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/pcan.2009.7","volume":"12","author":"D Gupta","year":"2009","unstructured":"Gupta, D., Lammersfeld, C. A., Trukova, K. & Lis, C. G. Vitamin D and prostate cancer risk: A review of the epidemiological literature. Prostate Cancer Prostatic Dis. 12, 215\u2013226 (2009).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"99786_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2009.11.024","volume":"62","author":"JI Silverberg","year":"2010","unstructured":"Silverberg, J. I., Silverberg, A. I., Malka, E. & Silverberg, N. B. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J. Am. Acad Dermatol. 62, 937\u2013941 (2010).","journal-title":"J. Am. Acad Dermatol."},{"issue":"4","key":"99786_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000354607","volume":"227","author":"VM Sheth","year":"2013","unstructured":"Sheth, V. M., Guo, Y. & Qureshi, A. A. Comorbidities associated with vitiligo: A ten-year retrospective study. Dermatology (Basel, Switzerland). 227(4), 311\u2013315 (2013).","journal-title":"Dermatology (Basel, Switzerland)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99786-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T20:11:04Z","timestamp":1699647064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99786-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99786"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99786-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20195"}}